suppl_file.zip (1 MB)
Supplementary Materials. Prognostic and predictive value of microsatellite instability (MSI) status among patients with colorectal cancer
dataset
posted on 2021-10-05, 10:17 authored by Firas Baidoun, Anas M Saad, Omar Abdel-RahmanSupplementary figure 1. Overall survival in (A) stage II CRC and (B) stage III patients according to MSI status.
Supplementary figure 2. Stage II CRC with high-risk features.
Supplementary figure 3. Overall survival in (A) MSI-H and (B) MSI-S stage II CRC patients with highest-risk features according to chemotherapy.
Supplementary figure 4. Stage II CRC without high-risk features.
Supplementary figure 5. Overall survival in (A) MSI-H stage III CRC patients with low-risk features and (B) MSI-H stage III CRC patients with high-risk features according to chemotherapy.
Supplementary figure A. Patient selection.
Supplementary figure B. Histogram for raw data and matched data (stage II MSI-H and high-risk features).
Supplementary figure C. Histogram for raw data and matched data (stage II MSI-H and without high-risk features).
Supplementary figure D. Histogram for raw data and matched data (stage II MSI-S and without high-risk features).
Supplementary Table A. Baseline characteristics of MSI-H stage II CRC patients with high-risk features according to chemotherapy after propensity score matching.
Supplementary Table B. Baseline characteristics of MSI-H stage II CRC patients without high-risk features according to chemotherapy after propensity score matching.
Supplementary Table C. Baseline characteristics of MSI-L stage II CRC patients without high-risk features according to chemotherapy after propensity score matching.
Supplementary Table D. Multivariate analysis for MSI known status stage II & III CRC patients.